Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.

G Sonpavde,G R Pond,G Di Lorenzo,C Buonerba,A Rozzi,G Lanzetta,A Necchi,P Giannatempo,D Raggi, K Matsumoto,T K Choueiri,S Mullane,G Niegisch,P Albers,J L Lee,H Kitamura,H Kume,J Bellmunt

Clinical Genitourinary Cancer（2016）

引用 1|浏览20

暂无评分

摘要

Prior platinum- versus non-platinum-based chemotherapy did not have a prognostic impact on OS after accounting for major prognostic factors in patients receiving salvage systemic chemotherapy for advanced urothelial carcinoma. Lack of prior platinum therapy should not disqualify patients from inclusion onto trials of salvage therapy.

查看译文

关键词

Chemotherapy,Overall survival,Prior platinum therapy,Salvage,Urothelial carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要